1) Loss of branched O-mannosyl glycans in astrocytes accelerates remyelination.
丂 Kanekiyo K, Inamori K, Kitazume S, Sato K, Maeda J, Higuchi M, Kizuka Y, Korekane H, Matsuo I, Honke K, Taniguchi
丂 N.
丂 J. Neurosci. 2013; 33:10037-10047 (IF: 6.908) 丂丂丂丂丂丂

2) Biosynthesis and biological function of sulfoglycolipids.
丂 Honke K.
丂 Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2013; 89:129-138 (review) (IF: 2.769)

3) Low affinity IgM antibodies lacking somatic hypermutations are produced in the secondary response of C57BL/6 mice
丂 to (4-hydroxy-3-nitrophenyl)acetyl hapten.
丂 Murakami A, Moriyama H, Osako-Kabasawa M, Endo K, Nishimura M, Udaka K, Muramatsu M, Honjo T, Azuma T, and
丂 Shimizu T.
丂 Int Immunol. 2013, 26(4):195-208.(IF:2.536)

4) Evaluating efficacy of bacteriophage therapy against Staphylococcus aureus infections using a silkworm larval infection
丂 model.
丂 Takemura-Uchiyama I, Uchiyama J, Kato S, Inoue T, Ujihara T, Ohara N, Daibata M, Matsuzaki S.
丂 FEMS Microbiol Lett. 2013 Oct;347(1):52-60. doi: 10.1111/1574-6968.12220. Epub 2013 Aug 6. IF(2014)丂2.121 丂丂丂丂丂

5) Characterization of Helicobacter pylori bacteriophage KHP30.
丂 Uchiyama J, Takeuchi H, Kato S, Gamoh K, Takemura-Uchiyama I, Ujihara T, Daibata M, Matsuzaki S.
丂 Appl Environ Microbiol. 2013 May;79(10):3176-84. doi: 10.1128/AEM.03530-12. Epub 2013 Mar 8. IF(2014)丂3.668 丂丂丂丂丂

6) Synergistic bacteriolysis by bacteriophage EF24C endolysin ORF9 and lantibiotic nisin and its application to pulsed-field
丂 gel electrophoreic analysis of Enterococcus faecalis.
丂 akemura-Uchiyama I, Uchiyama J, Satoh M, Uhihara T, Daibata M, Matsuzaki S.
丂 Annals of Microbiology. 63(3):1209-1211. 2013.丂IF (2014)丂0.990 丂丂丂丂丂丂

7) Radiographic Progression of Silicosis among Japanese Tunnel Workers in Kochi.
丂 Dumavibhat N, Matsui T, Hoshino E, Rattanasiri S, Muntham D, Hirota R, Eitoku M, Imanaka M, Muzembo BA, Ngatu
丂 NR, Kondo S, Hamada N, Suganuma N.
丂 J Occup Health.55(3):142-8, 2013 (IF: 1.109) 丂丂丂丂丂丂

8) Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapy.
丂 Yamazaki H丆Nakamura S丆Kobayashi K丆Tsubokura T丆Kodani N丆Aibe N丆Yoshida K丆Kagiya T丆Koizumi M丆
丂 Yamada K.
丂 Anticancer Res. 33:643-6丆2013 (IF: 1.826) 丂丂丂丂丂丂

9) Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-
丂 institution experience.
丂 Kobayashi K, Okihara K, Iwata T, Aibe N, Kodani N, Tsubokura T, Kamoi K, Miki T, Yamazaki H.
丂 J Radiat Res. 54(3):479-84, 2013 (IF: 1.797) 丂丂丂丂丂丂

10) Prediction of therapeutic effectiveness according to CT findings after therapeutic lymphangiography for lymphatic
丂 leakage.
丂 Yoshimatsu R, Yamagami T, Miura H, Matsumoto T.
丂 Jpn J Radiol.31: 797-802, 2013 (IF: 0.837) 丂

11) Therapeutic response to anew enzyme-targeting radiosensitization treatment (KORTUC-SC) forpatients with
丂 chemotherapy-resistant supraclavicular lymph nodemetastasis.
丂 Aoyama N, Ogawa Y, Kubota K, Ohgi K, Kataoka Y, Miyatake K,Tadokoro M, Yamanishi T, Ohnishi T, Hamada N,
丂 Kariya S, Tamura T, Nogami M, Nishioka A, Onogawa M, Miyahara M.
丂 J Cancer Res Ther. 1:215-9, 2013 (IF: 0.791)

1) 8487076乮US乯
丂 HLA亅binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide.
丂 Tomoya Miyakawa, Keiko Udaka
丂 2013.7.16

1) Udaka K:
丂 Development of WT1 Peptide and B. pertussis whole cell vaccine.
丂 Symposium National Vaccine Research Forum (NVRF) 2013.7.2-3,丂Jakarta(Indonesia)

2) Nogami M, KataokaY, Ohnishi T, Kohsaki S, Miyatake K, Akagi N and OgawaY:
丂 Diagnostic performance of 18F-FDG PET after diuretic for the upper urinary tract carcinomas: non-contrast PET/MRI
丂 fusion versus contrast-enhanced PET/CT.
丂 Society of Nuclear Medicine 2013. Vancouver BC, Canada. 2013/6/8-12

3) Nogami M, Kataoka Y, Kohsaki S, Miyatake K, Akagi N and Ogawa Y:
丂 Diagnostic impact of 18F-FDG PET/CT after diuretic for the upper urinary tract carcinomas:Comparison with standard
丂 PET/CT and PET/contrast-enhanced CT.
丂 European Association of Nuclear Medicine 2013. Lyon, France. 2013/10/19-23

4) Kobayashi K , Okihara K, Iwata T,, Kamoi K, Miki T, Yamazaki H:
丂 Permanent Prostate Brachytherapy In Patients With Small Prostate Gland Volume <20cm3.
丂 American Brachytherapy Society Annual meeting. New Orleans, USA. 2013/4/20

崙撪妛夛

1) 杮壠岶堦丄嶳岥垷棙嵐丄彫扟揟峅丗
丂 GPI-傾儞僇乕宆HRP梈崌僞儞僷僋幙偑偮偔傞帀幙儔僼僩僪儊僀儞
丂 戞86夞擔杮惗壔妛夛戝夛丄僔儞億僕僂儉丄暯惉25擭9寧12擔丄僷僔僼傿僐墶昹

2) 徏嶈栁揥丄撪嶳弤暯丄撪嶳乮抾懞乯埳戙丄戝敤夒揟丗
丂 僶僋僥儕僆僼傽乕僕尋媶偺尰忬偲揥朷
丂 戞4夞垽昋旝惗暔僱僢僩儚乕僋僼僅乕儔儉丄垽昋丄2013.11.2. 乮垽昋戝妛憤崌尋媶搹) 丂丂丂丂

3) 惣壀柧恖丗
丂 擕娻偺曻幩慄帯椕
丂 戞73夞擔杮堛妛曻幩慄妛夛憤夛丄墶昹丄2013/4/10-13

4) 媑徏棞崄丗
丂 惷柆寣愷嵡愷徢偺IVR(IVC僼傿儖僞乕傪娷傓)(婎慴偐傜墳梡傑偱)乮壞婜僙儈僫乕偺撪梕傪娷傓乯
丂 戞42夞IVR妛夛憤夛媄弍嫵堢僙儈僫乕3丄寉堜戲丄2013巗

1) Evaluation of a novel artificial pancreas: closed loop glycemic control system with continuous blood glucose
丂 monitoring.
丂 Tsukamoto Y, Kinoshita Y, Kitagawa H, Munekage M, Munekage E, Takezaki Y, Yatabe T, Yamashita K, Yamazaki R,
丂 Okabayashi T, Tarumi M, Kobayashi M, Mishina S, Hanazaki K.
丂 Artificial Organs. 2013 37(4)Apr:E67-73. (IF 1.870)

2) Perioperative glycemic control using an artificial endocrine pancreas in patients undergoing total pancreatectomy:
丂 tight glycemic control may be justified in order to avoid brittle diabetes.
丂 Hanazaki K, Yatabe T, Kobayashi M, Tsukamoto Y, Kinoshita Y, Munekage M, Kitagawa H.
丂 Biomed Mater Eng. 2013 23(1):109-116. (IF 0.847)

3) Hassanain M et al.: Randomized clinical trial of the impact of insulin therapy on liver function in patients undergoing
丂 major liver resection (Br J Surg 100(5):610-618, 2013).
丂 Hanazaki K, Munekage M, Kitagawa H, Namikawa T.
丂 Br J Surg. 2013 Website:Your Views. 2013 May 2. (IF -)

4) Ischemic preconditioning may reduce hyperglycemia associated with intermittent pringle maneuver in hepatic
丂 resection.
丂 Hanazaki K, Munekage M, Ichikawa K, Okabayashi T.
丂 J Hepatobiliary Pancreat Sci. 2013 20(2):257. (IF 2.313)

5) Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with
丂 hepatocellular carcinoma: a prospective study.
丂 Ichikawa K, Okabayashi T, Maeda H, Namikawa T, Iiyama T, Sugimoto T, Kobayashi M, Mimura T, Hanazaki K.
丂 Surg Today. 2013 43(7):720-726. (IF 1.208)

6) Report from the committee for improving the work environment of Japanese surgeons: survey on effects of the fee
丂 revision for medical services provided by surgeons.
丂 Hanazaki K, Tominaga R, Nio M, Iwanaka T, Okoshi K, Kaneko K, Nagano H, Nishida T, Nishida H, Hoshino K, Maehara
丂 T, Masuda M, Matsufuji H, Yanaga K, Tabayashi K, Satomi S, Kokudo N.
丂 Surg Today. 2013 43(11):1209-1218. (IF 1.208)

7) Effect of Daikenchuto (TJ-100) on abdominal bloating in hepatectomized patients.
丂 Hanazaki K, Ichikawa K, Munekage M, Kitagawa H, Dabanaka K, Namikawa T.
丂 World J Gastrointest Surg. 2013 5(4):115-122. (IF -)

8) Development of perioperative glycemic control using an artificial endocrine pancreas.
丂 Hanazaki K, Namikawa T.
丂 IEEE Eng Med Biol Soc. 2013:5719-5722. (IF -)

9) Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury.
丂 Ishihara M, Urushido M, Hamada K, Matsumoto T, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Horino T, Fujieda M,
丂 Terada Y.
丂 Am J Physiol Renal Physiol. 305(4):F495-509, 2013.丂(IF:3.248)

10) Effects of Gold Thioglucose Treatment on Central Corticotrophin-Releasing Hormone Systems in Mice.
丂 Noguchi T丆Makino S丆Shinohara M丆Nishiyama M, Hashimoto K丆Terada Y.
丂 Journal of Neuroendocrinolory. 25(4)丗340-349丆2013 (IF:3.138)

11) Imaging assessment of enthesitis in spondyloarthritis.
丂 Taniguchi Y, Kumon Y, Takata T, Sano S, Ohnishi T, Nogami M, Ogawa Y, Terada Y.
丂 Annals of Nuclear Medicine. 27 (2):105-111丆2013丏(IF:1.677)

12) Clinical implication of FDG-PET/CT in monitoring disease activity in lgG4-related disease.
丂 Taniguchi Y, Ogata K, Inoue K, Terada Y.
丂 Rheumatology (Oxford). 52 (8):1508丆2013丏(IF:4.475)

13) 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer
丂 efficiency of cisplatin in rats in vitro and in vivo.
丂 Terada Y, Inoue K, Matsumoto T, Ishihara M, Hamada K, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Horino T,
丂 Karashima T, Tamura K, Fukuhara H, Fujimoto S, Tsuda M, Shuin T.
丂 PLoS one. 8(12):e80850. 2013. (IF:3.234)

14) Lupus nephritis with positive myeloperoxidase/proteinase 3-antineutrophil cytoplasmic autoantibody that developed
丂 after 17 years of propylthiouracil therapy.
丂 Taguchi T, Nakayama S, Fujimoto S, Terada Y.
丂 Endocrine. 46(2):357-359, 2013. (IF:3.878)

15) Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease.
丂 Hamada K丆Taniguchi Y, Shimamura Y, Inoue K, Ogata K, Ishihara M, Horino T, Fujimoto S, Ohguro T, Yoshimoto Y,
丂 Ikebe M, Yuasa K, Hoshino E, Iiyama T, Ichihara A, Terada Y.
丂 Clin Exp Nephrol. 17(6):848-856, 2013. (IF:2.020)

16) Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through
丂 hypoxia-inducible factor-1兛-related defense mechanisms.
丂 Kakinuma Y, Tsuda M, Okazaki K, Akiyama T, Arikawa M, Noguchi T, Sato T.
丂 J Am Heart Assoc. 2013 Jan 18;2(1):e004887乮IF:4.306乯

17) The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat
丂 model of Parkinson's disease.
丂 Thomas Tayra J, Kameda M, Yasuhara T, Agari T, Kadota T, Wang F, Kikuchi Y, Liang H, Shinko A, Wakamori T,
丂 Vcelar B, Weik R, Date I.
丂 Brain Res. 2013 Mar 28;1502:55-70乮IF: 2.843乯

18) Oral administration of Ag suppresses Ag-induced allergic conjunctivitis in mice: critical timing and dose of Ag.
丂 Ishida W, Fukuda K, Harada Y, Sumi T, Taguchi O, Tsuda M, Yagita H, Fukushima A.
丂 Br J Ophthalmol. 2013 Apr;97(4):492-7乮IF:2.976乯

19) Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in
丂 urothelial carcinoma.
丂 Inoue K, Fukuhara H, Kurabayashi A, Furihata M, Tsuda M, Nagakawa K, Fujita H, Utsumi K, Shuin T.
丂 Cancer Sci. 2013 Jun;104(6):765-72乮IF:3.523乯

20) Mannitol enhances therapeutic effects of intra-arterial transplantation of mesenchymal stem cells into the brain after
丂 traumatic brain injury.
丂 Okuma Y, Wang F, Toyoshima A, Kameda M, Hishikawa T, Tokunaga K, Sugiu K, Liu K, Haruma J, Nishibori M,
丂 Yasuhara T, Date I.
丂 Neurosci Lett. 2013 Oct 25;554:156-61乮IF: 2.030乯

21) Neuroprotective effects of liraglutide for stroke model of rats.
丂 Sato K, Kameda M, Yasuhara T, Agari T, Baba T, Wang F, Shinko A, Wakamori T, Toyoshima A, Takeuchi H, Sasaki T,
丂 Sasada S, Kondo A, Borlongan CV, Matsumae M, Date I.
丂 Int J Mol Sci. 2013 Oct 30;14(11):21513-24乮IF:2.862乯

22) Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
丂 Yamada R, Maeda N, Oguri H, Adachi Y, Takeuchi T, Furihata M, Fukaya T.
丂 Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):96-100乮IF:1.695乯

1) Blood glucose control using an artificial pancreas reduces the workload of ICU nurses.
丂 Mibu K, Yatabe T, Hanazaki K.
丂 ATTD 2012 Yearbook, 4th ed, Phillip M and Battelino T eds, Mary Ann Liebert, pp67-69. 2013

2) 扟岥媊揟丄帥揷揟惗丗 丂
丂 14丂戙幱惈傾僔僪乕僔僗帯椕栻.丂恡憻昦栻暔椕朄幚慔僈僀僪丒嘥復 恡幘姵帯椕栻偺婎杮揑抦幆 丂
丂 扥塇棙廩曇廤pp145-149.丂拞嶳彂揦丄2013

3) 堜忋峢曘丄帥揷揟惗丗 丂
丂 17丂擜嵶娗惈傾僔僪乕僔僗.丂恡憻昦栻暔椕朄幚慔僈僀僪丒丂嘦復 幘姵暿張曽椺偺幚嵺 丂
丂 扥塇棙廩曇pp363-369丄丂拞嶳彂揦

4) 扟岥媊揟丄鸐揷壚庻丄搰懞朏巕丄帥揷揟惗丗 丂
丂 3丂栻暔帯椕丂棙擜栻.丂恡晄慡帯椕丂儗僔僺丒嘨丂枬惈恡晄慡帯椕乮曐懚婜偍傛傃摟愅乯 丂
丂 扥塇棙廩曇pp188-194丄堛妛弌斉丄2013

5) 帥揷揟惗丗 丂
丂 11-9丂擜嵶娗幘姵.丂戞10斉丂撪壢妛 丂
丂 栴�眿`梇曇廤pp1498-1505.丂 挬憅彂揦丄2013

1) Hanazaki K, Namikawa T.
丂 Development of perioperative glycemic control using an artificial endocrine pancreas.
丂 35th Annual International Conference IEEE EMBS, 2013.7.3-7.7, Osaka International Convention Center, Osaka,
丂 Japan.

崙撪妛夛

1) 帥揷揟惗
丂 AKI偱偺擜嵶娗忈奞偲嵞惗
丂 戞58夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛丂僔儞億僕僂儉1丂6丆20-23丆2013丂暉壀

2) 帥揷揟惗
丂 媫惈恡忈奞(AKI)偺嵟嬤偺榖戣乣擜嵶娗偺嵞惗偼偳偙傑偱壜擻偐乣
丂 戞58夞擔杮摟愅堛妛夛妛弍廤夛丒憤夛丂嫵堢島墘15丂6丆20-23丆2013丂暉壀

3) 慜揷挿惓
丂 醬捝傗夁懡寧宱傪敽偆巕媨椙惈幘姵偺帯椕偺幚嵺
丂 暯惉25擭搙彈惈堛椕僙儈僫乕丄2013擭7寧7擔丄搶嫗

4) 慜揷挿惓
丂 巕媨撪枌徢敪徢儊僇僯僘儉偺撲傪扵傞
丂 撧椙導嶻晈恖壢堛夛妛弍 島墘夛丄2013擭11寧14擔丄撧椙

5) 慜揷挿惓
丂 巕媨撪枌徢偺撲傪扵傞乗暊峯撪柶塽娐嫬傪峫嶡偟偰乗
丂 巕媨撪枌徢僼僅乕儔儉丄2013擭11寧29擔丄摽搰

6) 搒棷塸旤丄郪揷寬丄惣尨恀棟丄捗揷丂夒擵
丂 儕儞僷媴偵偍偗傞complexin偺敪尰偲婡擻
丂 戞36夞擔杮暘巕惗暔妛夛擭夛丄2013擭12寧3擔-6擔丄恄屗

1) Effectiveness of an artificial pancreas with closed-loop system to achieve tight glycemic control. 丂丂丂丂
丂 Asano T, Y. Kinoshita Y, Mibu K, Kitagawa H, Munekage M, Yatabe T, Yamazaki F, Hanazaki K.
丂 25th International Conference Society Medical Innovation Technology, 2nd Poster Prize, 2013. 9.5-9.7, Baden-Baden,
丂 Germany

2) 抇娗娻嵶朎姅偵偍偗傞僾儘僥傾僜乗儉慾奞嵻儃儖僥僝儈僽偵傛傞峈庮釃岠壥偺憹嫮. 丂丂丂丂
丂 抾�睏R壚丄彫嶳撪惤丄擇懞梇夘丄廆宨嫥嵠丄壴�睒a峅
丂 戞31夞擔杮僸僩嵶朎妛夛妛弍廤夛丄儎儞僌僒僀僄儞僥傿僗僩徿丄2013.8.10-8.11, 強戲

丂 崅抦怴暦丂2013擭12寧19擔
丂 偑傫岝傜偣傞傾儈僲巁丗媫惈恡忈奞杊偖岠壥

1) Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
丂 Kumagai N, Origasa H, Nagao T, Takekawa H, Okuhara Y, Yamaguchi T.
丂 J Stroke Cerebrovasc Dis. 22(6):792-8. 2013 (IF:1.669)

2) Effects of smoking on outcomes after acute atherothrombotic stroke in Japanese men.
丂 Kumagai N, Okuhara Y, Iiyama T, Fujimoto Y, Takekawa H, Origasa H, Kawanishi Y, Yamaguchi T.
丂 Journal of the Neurological Sciences. 335(1-2):164-168, 2013 (IF:2.474)

3) Heavy alcohol intake is a risk factor for esophageal squamous cell carcinoma among middle-aged men: A case-control
丂 and simulation study.
丂 Naoko Kumagai, Toshifumi Wakai, Kohei Akazawa, Yiwei Ling, Shijie Wang, Baoen Shan, Yoshiyasu Okuhara, Yutaka
丂 Hatakeyama, Hiromi Kataoka.
丂 Molecular and Clinical Oncology. 1, 811-816, 2013.

4) Spatial distribution of selection pressure on a protein based on the hierarchical Bayesian model.
丂 Watabe T, Kishino H.
丂 Mol Biol Evol. 2013 Dec;30(12):2714-22. doi: 10.1093/molbev/mst151. Epub 2013 Sep 2.(IF:9.105)

5) Liver acid sphingomyelinase inhibits growth of metastatic colon cancer.
丂 Osawa Y, Suetsugu A, Matsushima-Nishiwaki R, Yasuda I, Saibara T, Moriwaki H, Seishima M, Kozawa O.
丂 J Clin Invest. 2013 Feb;123(2):834-43. doi: 10.1172/JCI65188. Epub 2013 Jan 9. (IF 13.765)

6) Hepatocyte destruction with enhanced collagen synthesis: characteristic feature of chronic hepatitis C patients on
丂 haemodialysis.
丂 Ue M, Ikebe N, Munekage K, Ochi T, Hirose A, Kataoka H, Fujimoto S, Kikuchi K, Okuhara Y, Ono M, Saibara T.
丂 J Viral Hepat. 2013 May;20(5):350-7. doi: 10.1111/jvh.12031. Epub 2012 Dec 11. (IF 3.307)

7) Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase
丂 levels.
丂 Yoneda M, Imajo K, Eguchi Y, Fujii H, Sumida Y, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Aoki N, Sata M, Kanemasa
丂 K, Kohgo Y, Saibara T, Chayama K, Itoh Y, Yoshikawa T, Anzai K, Fujimoto K, Okanoue T, Nakajima A; Japan Study
丂 Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
丂 J Gastroenterol. 2013 Sep;48(9):1051-60. doi: 10.1007/s00535-012- 0704-y. Epub 2012 Nov 27. (IF 3.307)

8) Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver
丂 disease.
丂 Hashiba M, Ono M, Hyogo H, Ikeda Y, Masuda K, Yoshioka R, Ishikawa Y, Nagata Y, Munekage K, Ochi T, Hirose A,
丂 Nozaki-Fujimura Y, Noguchi S, Okamoto N, Chayama K, Suganuma N, Saibara T.
丂 PLoS One. 2013 Nov 6;8(11):e76161. doi: 10.1371/journal.pone.0076161. eCollection 2013. (IF 3.534)

9) Tumor necrosis factor-兛 promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of
丂 metalloproteinase-1 production in hepatic stellate cells.
丂 Osawa Y, Hoshi M, Yasuda I, Saibara T, Moriwaki H, Kozawa O.
丂 PLoS One. 2013 Jun 3;8(6):e65251. doi: 10.1371/journal.pone.0065251. Print 2013. (IF 3.534)

10) Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
丂 Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, Iiyama T, Kumagai N, Tanioka K, Yamasaki N,
丂 Matsumura Y, Furuno T, Sugiura T, Doi YL.
丂 J Am Coll Cardiol. 2013 Oct 1;62(14):1252-9. 乮IF 16.503乯

11) Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic
丂 cardiomyopathy.
丂 Kitaoka H, Kubo T, Hayashi K, Yamasaki N, Matsumura Y, Furuno T, Doi YL.
丂 Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):544-9. 乮IF 4.105乯

12) Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy:
丂 results from multicenter registration in Japan.
丂 Fujita T, Fujino N, Anan R, Tei C, Kubo T, Doi Y, Kinugawa S, Tsutsui H, Kobayashi S, Yano M, Asakura M, Kitakaze M,
丂 Komuro I, Konno T, Hayashi K, Kawashiri MA, Ino H, Yamagishi M.
丂 JACC Heart Fail. 2013 Dec;1(6):459-66.

1) 惣尨棙帯丄彫栰惓暥 丂丂丂丂丂丂丂
丂 NAFLD乮NASH/NAFL乯 丂
丂 悰栰寬懢榊丒忋惣婭晇丒堜夢摴晇曇丄徚壔婍幘姵丂嵟怴偺帯椕2012-2013丄328-331丄撿峕摪丄彫棫忁旻丄搶嫗丄2013丏

2) 惣尨棙帯 丂丂丂丂丂丂丂
丂 戙幱惈娞幘姵丂椪彴昦懺妛俀 丂
丂 悰栰寬懢榊曇丂133-135暸丄丂丂僰乕償僃儖僸儘僇儚丄搶嫗丄2013

3) 惣尨棙帯 丂丂丂丂丂丂丂
丂 旍枮徢偲帀朾娞丄NASH 撪暘斿戙幱妛 丂
丂 拞旜堦榓曇丂449-450暸丄恌抐偲帯椕幮丄搶嫗丄2013

4) 崢嶳桾堦丄搾愳怶峅丄惣尨棙帯 丂丂丂丂丂丂丂
丂 儊僞儃娞娻偺崅婋尟孮嘆丂儊僞儃娞娻 丂
丂 彫枔惌抝曇丂97-101暸丄傾乕僋儊僨傿傾丄搶嫗丄2013

5) 惣尨棙帯 丂丂丂丂丂丂丂
丂 帀朾惈娞幘姵乮NAFLD丒NASH乯 丂
丂 堦悾夒晇丒壀惌巙丒帩揷抭曇丄帯椕夁掱偱堦栚偱傢偐傞徚壔婍栻暔椕朄STEP1丒2丒3丄217-220丄儊僕僇儖價儏乕幮丄愺尨幚
丂 榊丄搶嫗丄2013

6) 惣尨棙帯 丂丂丂丂丂丂丂
丂 嘨 帯椕曇 1 帯椕妛憤榑 丂
丂 抾堜尓擵丒抾尨揙榊丒帩揷抭曇丄NASH丒傾儖僐乕儖惈娞忈奞丄166-171丄暥岝摪丄愺堜岹桽丄搶嫗丄2013.

7) 惣尨棙帯丄彫栰惓暥 丂丂丂丂丂丂丂
丂 旕傾儖僐乕儖惈帀朾娞墛乮NASH乯 丂
丂 壓悾愳揙丒搉曈庣丒栘壓朏堦丒嬥巕廃堦丒妦揷攷巎曇丄愱栧堛偺偨傔偺徚壔婍昦妛 戞2斉丄381-385丄堛妛彂堾丄嬥尨桪丄搶
丂 嫗丄2013.

8) 彫栰惓暥丄惣尨棙帯 丂丂丂丂丂丂丂
丂 Debate 栻暔婲場偵傛傞乬NASH乭偼NASH偱偼側偄丠 丂
丂 抾堜尓擵丒抾尨揙榊丒帩揷抭曇丆NASH丒傾儖僐乕儖惈娞忈奞丄105-109丄暥岝摪丄愺堜岹桽丄搶嫗丄2013.

9) 廆宨尯桽丄彫栰惓暥丄惣尨棙帯 丂丂丂丂丂丂丂
丂 僇儔乕斉 徚壔婍昦妛 婎慴偲椪彴 丂
丂 愺崄惓攷丒悰栰寬懢榊丒愮梩曌曇丄7 旕傾儖僐乕儖惈帀朾惈娞幘姵丄1217-1221丄惣懞彂揦丄惣懞惓摽丄搶嫗丄2013

崙撪妛夛

1) Kubo T.
丂 Meet the expert: Hypertrophic cardiomyopahty: an update.
丂 The 77th Annual Scientific Meeting of the Japanese Circulation Society, Yokohama, 2013

2) 媣曐嫓
丂 怱晄慡偵愽傓僼傽僽儕乕昦
丂 戞17夞擔杮怱晄慡妛夛妛弍廤夛儌乕僯儞僌僙儈僫乕丗嶉嬍丄 2013

1) 戝桭榓懃乮愭抂堛椕妛僐乕僗堛妛壢4擭惗乮敪昞帪乯乯 丂丂丂丂丂丂丂
丂 桪廏墘戣徿 丂
丂 戞56夞擔杮恡憻妛夛妛弍憤夛偱峴偭偨岥摢敪昞乽昦堾忣曬僔僗僥儉僨乕僞儀乕僗偺栐梾揑夝愅偵傛傞媫惈恡忈奞(AKI)偵偍偗傞儕
丂 僗僋幘姵偺扵媶乿偑乽桪廏墘戣徿乿傪庴徿偟偨丅

2) 愇嫶抦柧乮愭抂堛椕妛僐乕僗堛妛壢3擭惗乮敪昞帪乯乯 丂丂丂丂丂丂丂
丂 尋媶彠椼徿 丂
丂 2012擭搙偺戞32夞堛椕忣曬妛楢崌戝夛偱峴偭偨岥摢敪昞乽嫬奅宆摐擜昦偺憗婜敪尒偺偨傔偺専嵏僨乕僞偺栐梾揑扵嶕乿偑乽尋媶
丂 彠椼徿乿傪庴徿偟丄2013擭6寧偺丄戞17夞擔杮堛椕忣曬妛夛弔婫妛弍戝夛偱昞彶偝傟偨丅

1) Activation of ATP-sensitive potassium channels by nicorandil is preserved in aged vascular smooth muscle cells in rats.
丂 Yamazaki F, Chi H, Eguchi S, Kawano T.
丂 J Anesth. 2013; 27: 623-6. (IF 1.176)

2) Preoperative oral rehydration therapy with 2.5% carbohydrate beverage alleviates insulin action in volunteers.
丂 Yatabe T, Tamura T, Kitagawa H, Namikawa T, Yamashita K, Hanazaki K, Yokoyama M.
丂 J Artif Organs. 2013; 16: 483-8. (IF 1.441)

3) Influence of administration of 1 % glucose solution on neonatal blood glucose concentration in cesarean section.
丂 Yatabe T, Tateiwa H, Ikenoue N, Kitamura S, Yamashita K, Yokoyama M.
丂 J Anesth. 2013; 27: 302-5. (IF=1.176)

4) Postoperative pain impairs subsequent performance on a spatial memory task via effects on N-methyl-d-aspartate
丂 receptor in aged rats.
丂 Chi H, Kawano T, Tamura T, Iwata H, Takahashi Y, Eguchi S, Yamazaki F, Kumagai N, Yokoyama M.
丂 Life Sci. 2013; 93: 986-93. (IF 2.702)

挊彂

1) 埨揷惤巎
丂4-1 崅楊幰憤崌婡擻昡壙乮CGA乯丄4-2 榁擭徢岓孮丄4-3 榁擭昦偺 奣榑丄4-4 榁擭婜偵偍偗傞恎懱幘姵丏
丂埨懞惤巌丄峛斻堦榊丂曇廤丏崅楊幰曐寬暉巸儅僯儏傾儖丂pp36-38丂撿嶳摪丂搶嫗丂2013擭

2) 栴揷晹抭徍丄墶嶳惓彯
丂杻悓壢堛偺偨傔偺弞娐娗棟偺幚嵺乮墶嶳惓彯 愱栧曇廤乯
丂1-2弍慜桝塼娗棟偺峫偊曽 9-12丄拞嶳彂揦丄搶嫗丄2013

2) 栴揷晹抭徍丄墶嶳惓彯
丂杻悓壢堛偺偨傔偺弞娐娗棟偺幚嵺乮墶嶳惓彯 愱栧曇廤乯
丂1-2弍慜桝塼娗棟偺峫偊曽 9-12丄拞嶳彂揦丄搶嫗丄2013

3) 壨栰悞丄墶嶳惓彯
丂杻悓壢堛偺偨傔偺弞娐娗棟偺幚嵺乮墶嶳惓彯 愱栧曇廤乯
丂3-5怱憻儁乕僔儞僌僨僶僀僗憰拝姵幰 70-5丄拞嶳彂揦丄搶嫗丄2013

4) 嶳壓岾堦丄墶嶳惓彯
丂杻悓壢堛偺偨傔偺弞娐娗棟偺幚嵺乮墶嶳惓彯 愱栧曇廤乯
丂5-4 弞娐娗棟偺怴偨側巜昗偲壜擻惈 144-52丄拞嶳彂揦丄搶嫗丄2013

5) 壨栰悞丆 戝壓廋憿
丂杻悓壢堛偺偨傔偺弞娐娗棟偺幚嵺乮墶嶳惓彯 愱栧曇廤乯
丂8-5 IABP偺揔墳偲尷奅 267-72丄拞嶳彂揦丄搶嫗丄2013

6) 壨栰悞
丂庤弍捝偲弍屻擣抦婡擻忈奞
丂庤弍屻捔捝偺偡傋偰. VI復 pp 227-228丄暥岝摪丄2013

7) 壨栰 悞丄墶嶳惓彯
丂捝傒偺Science & practice
丂2捝傒偺栻暔帯椕. 嘩 捝傒偺尨場偲捔捝栻偺慖戰. 3 墛徢捝. 暥岝摪 2013. pp 260-264.

1) Yasumitsu-Lovell K, Minami M, Eitoku M, Suganuma N, Nakayama S.
丂 The Japan Environment and Children's Study (JECS)-JECS in Kochi prefecture as one of the fiftenn Regional Centres-
丂 僄僕儞僶儔GUSS: Growing Up in Scotland and Scandinavia, 2013/11/3, Edinburgh, Scotland

崙撪妛夛

1) 挿栰廋
丂 戝婯柾RCT偺寢壥傪庴偗偰偺採尵
丂 僔儞億僕僂儉丗惉恖ARDS偵懳偡傞崅昿搙怳摦姺婥乮HFOV乯丄戞35夞擔杮屇媧椕朄堛妛夛丄 2013擭7寧21擔丄搶嫗搒

2) 栴揷晹抭徍丄揷懞婱旻丄墶嶳惓彯
丂 弍慜偺扽悈壔暔晧壸偲寣摐丒懱壏娗棟偵偮偄偰
丂 擔杮杻悓壢妛夛戞60夞妛弍廤夛丄2013.5.23-25 嶥杫 乮僔儞億僕僂儉乯

3) 壨栰 悞
丂 憂彎帯桙夁掱偱偺拞悤恄宱偺曄壔 -弍屻捝偲擣抦婡擻偺娭學-
丂 擔杮杻悓壢妛夛 戞60夞妛弍廤夛 2013. 5.23-25. 嶥杫 乮僔儞億僕僂儉乯

4) 崅抦巗撪彫帣壢堛愢柧夛
丂 僄僐僠儖挷嵏偺奣梫偵偮偄偰丄2013/4/13丄 崅抦巗

5) 悰徖惉暥
丂 暯惉俀係擭搙崅抦嶻壢晈恖壢妛夛媦傃崅抦導嶻晈恖壢堛夛掕椺憤夛
丂 2013/5/25丄崅抦巗

6) 埨栰抭嵠(崙棫昦堾婡峔崅抦昦堾専嵏壢)
丂 崅抦偱峀偑傞僄僐僠儖挷嵏
丂 崙椪嫤拞巐崙巟晹崌摨妛夛(戞侾夞崙椪嫤拞巐崙巟晹憤夛)丄2013/9/7丄 壀嶳巗

7) 悰徖惉暥
丂 僄僐僠儖挷嵏偺恑捇忬嫷偲幘姵忣曬搊榐丒徻嵶挷嵏偵偮偄偰
丂 戞俉係夞擔杮彫帣壢妛夛崅抦抧曽夛丄2013/9/22丄崅抦巗

8) 埨岝儔償僃儖崄曐巕
丂 巕偳傕偺寬峃偲娐嫬偵娭偡傞慡崙挷嵏(僄僐僠儖挷嵏)丂崅抦儐僯僢僩僙儞僞乕偵丂丂偍偗傞恑捇曬崘丒峀曬媦傃僼僅儘乕傾僢僾偺
丂 庢傝慻傒偵偮偄偰
丂 擔杮撪暘斿奾棎壢妛暔幙妛夛(娐嫬儂儖儌儞妛夛)戞侾俇夞尋媶敪昞丄2013/12/13丄搶嫗

9) 撿傑傝側
丂 偙偆偪僄僐僠儖挷嵏偺恑捇忬嫷
丂 戞俇俁夞崅抦嶻壢晈恖壢妛夛妛弍廤夛丄2013/12/21

1) 擔杮杻悓壢妛夛戞60夞妛弍廤夛 嵟桪廏墘戣徿

2) 戞6夞塣摦婍醬捝妛夛 嵟桪廏墘戣徿

丂 1) 2013/7/30 儔僕僆曻憲乮RKC儔僕僆乯丗婥偵側傞寬峃僼傽儈儕乕僪僋僞乕 乽抦偭偰偍偒偨偄怱攛慼惗朄乿丄挿栰廋

丂 2) 2013/7 抧堟忣曬帍 偼偨傕乣傜乮暯惉25擭7寧崋乯僄僐僠儖挷嵏偵偮偄偰丂嶲壛幰5,000恖挻

丂 3) 2013/7/18 僥儗價 KSS偝傫偝傫僥儗價 乽偝傫偝傫PickUp乿

丂 4) 2013/7/19 僥儗價 RKC崅抦曻憲TV 偙偆偪eye僾儔僗

丂 5) 2013/7/30 僥儗價 KUTV僥儗價崅抦 乽儂僢僩崘抦斅乿

丂 6) 2013/8/31 怴暦乮挬姧乯崅抦怴暦丂導撪擠晈慡崙2攞偺昿搙偱儅僌儘傗僇僣僆愛庢

丂 7) 2013/9/25 嶨帍 傎偭偲偙偆偪乽儅儅偺杮乿僄僐僠儖徯夘

丂 8) 2013/10丂 抧堟忣曬帍 偼偨傕乣傜乮暯惉25擭10寧崋乯

1) Effects of Goishi tea on diet-induced obesity in mice Original Research Article.
丂 YKohei Jobu, Junko Yokota, Saburo Yoshioka, Hironori Moriyama, Shuzo Murata, Masao Ohishi, Hiroyuki Ukeda,
丂 Mitsuhiko Miyamura.
丂 Food Research International. 2013 Nov; 54(1): 324-329(IF:2.818)

2) Application of 5-aminolevulinic acid-mediated photodynamic diagnosis to robot-assisted laparoscopic radical
丂 prostatectomy.
丂 Inoue K, Ashida S, Fukuhara H, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Shuin T.
丂 Urology. 2013 Nov;82(5):1175-8.乮IF 2.188(2014)乯

3) Effects of smoking on outcomes after acute atherothrombotic stroke in Japanese men.
丂 Kumagai N, Okuhara Y, Iiyama T, Fujimoto Y, Takekawa H, Origasa H, Kawanishi Y, Yamaguchi T.
丂 J Neurol Sci. 2013 Dec 15;335(1-2):164-8.乮IF 2.474 (2014)乯

4) Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
丂 Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, Iiyama T, Kumagai N, Tanioka K, Yamasaki N,
丂 Matsumura Y, Furuno T, Sugiura T, Doi YL.
丂 J Am Coll Cardiol. 2013 Oct 1;62(14):1252-9.乮IF 16.503 (2014)乯

5) Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease.
丂 Hamada K, Taniguchi Y, Shimamura Y, Inoue K, Ogata K, Ishihara M, Horino T, Fujimoto S, Ohguro T, Yoshimoto Y,
丂 Ikebe M, Yuasa K, Hoshino E, Iiyama T, Ichihara A, Terada Y.
丂 Clin Exp Nephrol. 2013 Dec;17(6):848-56.乮IF 2.020 (2014)乯

6) Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with
丂 hepatocellular carcinoma: a prospective study.
丂 Ichikawa K, Okabayashi T, Maeda H, Namikawa T, Iiyama T, Sugimoto T, Kobayashi M, Mimura T, Hanazaki K.
丂 Surg Today. 2013 Jul;43(7):720-6.乮IF 1.526 (2014)乯

1) 忢晽嫽暯 丂丂丂丂丂丂丂
丂 暯惉25擭搙搙崅抦戝妛堛妛晹晬懏昦堾丂庒庤尋媶幰徿 丂